BIOVENTUS INC - A (BVS) Stock Fundamental Analysis
NASDAQ:BVS - Nasdaq - US09075A1088 - Common Stock - Currency: USD
Taking everything into account, BVS scores 4 out of 10 in our fundamental rating. BVS was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While BVS is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on BVS.
1. Profitability
1.1 Basic Checks
In the past year BVS was profitable.
BVS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BVS reported negative net income in multiple years.
Of the past 5 years BVS 4 years had a positive operating cash flow.
1.2 Ratios
BVS has a Return On Assets of -4.61%. This is in the better half of the industry: BVS outperforms 65.08% of its industry peers.
The Return On Equity of BVS (-22.67%) is better than 60.32% of its industry peers.
With a decent Return On Invested Capital value of 3.76%, BVS is doing good in the industry, outperforming 74.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.61% | ||
| ROE | -22.67% | ||
| ROIC | 3.76% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 4.29%, BVS is in the better half of the industry, outperforming 70.90% of the companies in the same industry.
In the last couple of years the Operating Margin of BVS has declined.
Looking at the Gross Margin, with a value of 67.72%, BVS is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
In the last couple of years the Gross Margin of BVS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.29% | ||
| PM (TTM) | N/A | ||
| GM | 67.72% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BVS is destroying value.
BVS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BVS has been increased compared to 5 years ago.
The debt/assets ratio for BVS has been reduced compared to a year ago.
2.2 Solvency
BVS has an Altman-Z score of 0.96. This is a bad value and indicates that BVS is not financially healthy and even has some risk of bankruptcy.
BVS has a Altman-Z score (0.96) which is in line with its industry peers.
BVS has a debt to FCF ratio of 9.16. This is a negative value and a sign of low solvency as BVS would need 9.16 years to pay back of all of its debts.
BVS has a better Debt to FCF ratio (9.16) than 75.13% of its industry peers.
BVS has a Debt/Equity ratio of 2.15. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.15, BVS is not doing good in the industry: 83.60% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.15 | ||
| Debt/FCF | 9.16 | ||
| Altman-Z | 0.96 |
ROIC/WACC0.38
WACC9.91%
2.3 Liquidity
BVS has a Current Ratio of 1.31. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
BVS has a Current ratio of 1.31. This is in the lower half of the industry: BVS underperforms 79.37% of its industry peers.
BVS has a Quick Ratio of 1.31. This is a bad value and indicates that BVS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.87, BVS is not doing good in the industry: 82.54% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.31 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 79.22% over the past year.
BVS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.93% yearly.
BVS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.88%.
Measured over the past years, BVS shows a quite strong growth in Revenue. The Revenue has been growing by 11.01% on average per year.
EPS 1Y (TTM)79.22%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%114.29%
Revenue 1Y (TTM)11.88%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%13.45%
3.2 Future
The Earnings Per Share is expected to grow by 18.79% on average over the next years. This is quite good.
Based on estimates for the next years, BVS will show a small growth in Revenue. The Revenue will grow by 3.43% on average per year.
EPS Next Y41.11%
EPS Next 2Y35.15%
EPS Next 3Y18.79%
EPS Next 5YN/A
Revenue Next Year-0.01%
Revenue Next 2Y3%
Revenue Next 3Y3.43%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 15.55, BVS is valued correctly.
Based on the Price/Earnings ratio, BVS is valued cheaper than 83.60% of the companies in the same industry.
When comparing the Price/Earnings ratio of BVS to the average of the S&P500 Index (28.88), we can say BVS is valued slightly cheaper.
A Price/Forward Earnings ratio of 11.02 indicates a reasonable valuation of BVS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 93.12% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BVS to the average of the S&P500 Index (21.20), we can say BVS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.55 | ||
| Fwd PE | 11.02 |
4.2 Price Multiples
BVS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BVS is cheaper than 85.71% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BVS is valued cheaply inside the industry as 89.42% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.85 | ||
| EV/EBITDA | 12.46 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BVS's earnings are expected to grow with 18.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y35.15%
EPS Next 3Y18.79%
5. Dividend
5.1 Amount
BVS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.31
-0.25 (-3.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners70.7%
Inst Owner Change-0.19%
Ins Owners2.11%
Ins Owner Change2.24%
Market Cap598.98M
Analysts77.14
Price Target15.3 (109.3%)
Short Float %1.34%
Short Ratio2.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)88.12%
Min EPS beat(2)78.22%
Max EPS beat(2)98.02%
EPS beat(4)4
Avg EPS beat(4)137.71%
Min EPS beat(4)78.22%
Max EPS beat(4)192.41%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.03%
Min Revenue beat(2)3.27%
Max Revenue beat(2)4.79%
Revenue beat(4)4
Avg Revenue beat(4)6.29%
Min Revenue beat(4)3.27%
Max Revenue beat(4)8.81%
Revenue beat(8)8
Avg Revenue beat(8)4.99%
Revenue beat(12)9
Avg Revenue beat(12)1.91%
Revenue beat(16)12
Avg Revenue beat(16)2.56%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-68.89%
EPS NY rev (1m)0%
EPS NY rev (3m)4.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.5%
Revenue NY rev (1m)1.85%
Revenue NY rev (3m)-1.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.55 | ||
| Fwd PE | 11.02 | ||
| P/S | 1.04 | ||
| P/FCF | 15.85 | ||
| P/OCF | 15.44 | ||
| P/B | 4.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.46 |
EPS(TTM)0.47
EY6.43%
EPS(NY)0.66
Fwd EY9.07%
FCF(TTM)0.46
FCFY6.31%
OCF(TTM)0.47
OCFY6.48%
SpS7
BVpS1.81
TBVpS-3.22
PEG (NY)0.38
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.61% | ||
| ROE | -22.67% | ||
| ROCE | 4.76% | ||
| ROIC | 3.76% | ||
| ROICexc | 4.09% | ||
| ROICexgc | 30.49% | ||
| OM | 4.29% | ||
| PM (TTM) | N/A | ||
| GM | 67.72% | ||
| FCFM | 6.59% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y44.62%
ROICexcg growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score6
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.15 | ||
| Debt/FCF | 9.16 | ||
| Debt/EBITDA | 4.29 | ||
| Cap/Depr | 2.03% | ||
| Cap/Sales | 0.18% | ||
| Interest Coverage | 0.64 | ||
| Cash Conversion | 52.3% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.31 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 0.96 |
F-Score6
WACC9.91%
ROIC/WACC0.38
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.22%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%114.29%
EPS Next Y41.11%
EPS Next 2Y35.15%
EPS Next 3Y18.79%
EPS Next 5YN/A
Revenue 1Y (TTM)11.88%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%13.45%
Revenue Next Year-0.01%
Revenue Next 2Y3%
Revenue Next 3Y3.43%
Revenue Next 5YN/A
EBIT growth 1Y1808.37%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year19.54%
EBIT Next 3Y13.24%
EBIT Next 5YN/A
FCF growth 1Y373.43%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y152.84%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%